Home / News / India News / Article /
Lupin buys anti-cholesterol drug rights for $39 mn
Updated On: 29 September, 2009 10:35 AM IST | | IANS
Indian pharmaceuticals major Lupin on Tuesday said it had acquired the rights for Antara, a drug to treat high blood cholesterol and high triglycerides, for $38.61 million from the US-based Oscient Pharmaceuticals.
Listen to this article :
Indian pharmaceuticals major Lupin on Tuesday said it had acquired the rights for Antara, a drug to treat high blood cholesterol and high triglycerides, for $38.61 million from the US-based Oscient Pharmaceuticals.
The rights for the drug, along with related assets and inventories, have been acquired under the procedures of the US Bankruptcy Court, the company said in a regulatory filing with the Bombay Stock Exchange (BSE).
Read Next Story


